Ambu downgrades, will cut costs

The Danish medtech firm’s preliminary Q3 report for 2021/2022 announced a cost reduction program, which will affect staffing and is expected to yield DKK 250m (USD 34.1m) in annualized savings.
Photo: PR / Ambu
Photo: PR / Ambu
by manon skov buch, translated by daniel pedersen

On Wednesday, Danish medtech firm Ambu announced preliminary financial figures from the third quarter of fiscal 2021/2022 – alongside a guidance downgrade for the full-year and a cost reduction program meant to result in DKK 250m (USD 34.1m) annualized savings.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading